Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
Public ClinicalTrials.gov record NCT03032380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens
Study identification
- NCT ID
- NCT03032380
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Shionogi
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Cefiderocol Drug
- Linezolid Drug
- Meropenem Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2017
- Primary completion
- Feb 25, 2019
- Completion
- Mar 31, 2019
- Last update posted
- Nov 12, 2020
2017 – 2019
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shionogi Research Site | New Haven | Connecticut | 06511 | — |
| Shionogi Research Site | DeLand | Florida | 32720 | — |
| Shionogi Research Site | Chicago | Illinois | 60612 | — |
| Shionogi Research Site | Council Bluffs | Iowa | 51503 | — |
| Shionogi Research Site | Louisville | Kentucky | 40202 | — |
| Shionogi Research Site | Baton Rouge | Louisiana | 70808 | — |
| Shionogi Research Site | Shreveport | Louisiana | 71103 | — |
| Shionogi Research Site | Annapolis | Maryland | 21404 | — |
| Shionogi Research Site | Detroit | Michigan | 48201 | — |
| Shionogi Research Site | St Louis | Missouri | 63110-0250 | — |
| Shionogi Research Site | Cleveland | Ohio | 44106 | — |
| Shionogi Research Site | Columbus | Ohio | 43210-1267 | — |
| Shionogi Research Site | Bethlehem | Pennsylvania | 18105 | — |
| Shionogi Research Site | Philadelphia | Pennsylvania | 19141 | — |
| Shionogi Research Site | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03032380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03032380 live on ClinicalTrials.gov.